A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Ravulizumab in Complement-Inhibitor-Naive Adult Patients with Generalized Myasthenia Gravis
Administered By
Contributors
- Juel, Vern Charles Principal Investigator
Start/End
- June 18, 2019 - December 31, 2023